Spots Global Cancer Trial Database for urothelial carcinoma recurrent
Every month we try and update this database with for urothelial carcinoma recurrent cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| uTRACT Jelmyto Registry: A Registry of Patients With Upper Tract Urothelial Cancer (UTUC) Treated With Jelmyto | NCT05874921 | Urothelial Carc... Urothelial Carc... Urothelial Carc... Urothelial Carc... Urothelial Canc... Urothelial Carc... Carcinoma, Tran... Transitional Ce... | Jelmyto (mitomy... | 18 Years - | UroGen Pharma Ltd. | |
| Evaluating Safety and Efficacy of Verity-BCG in BCG-naïve Patients With Intermediate and High-risk Non-muscle Invasive Bladder (NMIBC) | NCT05037279 | Bladder Cancer Bladder Cancer ... Neoplasm Recurr... Urothelial Carc... Urothelial Carc... Non-Invasive Bl... | Bacillus Calmet... Bacillus Calmet... | 18 Years - | Verity Pharmaceuticals Inc. | |
| A Study of Pemigatinib in Non-muscle Invasive Bladder Cancer Patients With Recurrent Low- or Intermediate-Risk Tumors | NCT03914794 | Bladder Cancer NMIBC Non-Muscle Inva... Urothelial Carc... | Pemigatinib | 18 Years - | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | |
| Named Patient Program for Mitomycin for Pyelocalyceal Solution | NCT05494411 | Urothelial Canc... Urothelial Carc... Urothelial Carc... Urothelial Carc... Urothelial Carc... Urothelial Carc... | Mitomycin for p... | 18 Years - | UroGen Pharma Ltd. | |
| Evaluating Safety and Efficacy of Verity-BCG in BCG-naïve Patients With Intermediate and High-risk Non-muscle Invasive Bladder (NMIBC) | NCT05037279 | Bladder Cancer Bladder Cancer ... Neoplasm Recurr... Urothelial Carc... Urothelial Carc... Non-Invasive Bl... | Bacillus Calmet... Bacillus Calmet... | 18 Years - | Verity Pharmaceuticals Inc. | |
| En Bloc TURBT With Collins Loop vs Conventional TURBT | NCT05027412 | Bladder Cancer Bladder Neoplas... Bladder Urothel... Bladder Cancer ... Urothelial Carc... | En bloc TURBT C... Conventional TU... | 18 Years - | Hospital Universitario de Fuenlabrada | |
| A Phase 1 Dose-escalation Study of UGN-301 in Patients With Recurrent Non-muscle Invasive Bladder Cancer (NMIBC) | NCT05375903 | Non-muscle Inva... NMIBC Carcinoma in Si... Bladder Cancer Urothelial Carc... Urothelial Carc... | UGN-301 UGN-201 Gemcitabine | 18 Years - | UroGen Pharma Ltd. | |
| Named Patient Program for Mitomycin for Pyelocalyceal Solution | NCT05494411 | Urothelial Canc... Urothelial Carc... Urothelial Carc... Urothelial Carc... Urothelial Carc... Urothelial Carc... | Mitomycin for p... | 18 Years - | UroGen Pharma Ltd. | |
| A Phase 1 Dose-escalation Study of UGN-301 in Patients With Recurrent Non-muscle Invasive Bladder Cancer (NMIBC) | NCT05375903 | Non-muscle Inva... NMIBC Carcinoma in Si... Bladder Cancer Urothelial Carc... Urothelial Carc... | UGN-301 UGN-201 Gemcitabine | 18 Years - | UroGen Pharma Ltd. |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
